Roivant has its own TYK2/JAK1 inhibitor in development in the form of brepocitinib, which the biopharma licensed from Pfizer ...

In this study, participants were divided into three age groups: adults over 18 years, children aged 5 to under 18 years, and ...

Jefferies Global Healthcare Conference: Zymeworks' management will participate in one-on-one meetings and a fireside chat on ...

For the first quarter of 2025, the Wasatch Micro Cap Fund—Investor Class was down -16.57% but outperformed the benchmark ...

A San Diego biotech company is helping top research labs develop mRNA vaccines, including a vaccine for some types of cancer. Jaime Chambers reports. STORY: fox5sandiego.com ...

BioSpace examines the busiest corporate venture capital arms in the pharmaceutical industry. Novo Holdings, which made ...

Home Depot doesn’t expect to raise prices because of tariffs, saying it has spent years diversifying the sources for the ...

Genetic testing company 23andMe is being acquired, shortly after it declared bankruptcy months ago.

Prime Medicine, known for its goal of treating hundreds of diseases with CRISPR, says it's narrowing its focus to two. It ...

Smithfield lease Mass. biotech offered millions to manufacture skin in R.I. Boston biotech aims to put some skin in the RI ...

Durham-based Atsena Therapeutics has received Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) for ATSN-201, its gene therapy product for the ...

A Massachusetts-based wound care and sports medicine company announced plans for its brand-new biomanufacturing facility Tuesday in Smithfield.